Kamar yadda aka lura a cikin labarina na ƙarshe A kan guje wa “ƙarfin hali” na BioNTech na gwajin aminci na rigakafinta na Covid-19, waɗanda suka kafa BioNTech Ugur Sahin da Özlem Türeci sun yi iƙirari a cikin littafinsu. Alurar rigakafin cewa aikin rigakafin Covid-19 na kamfanin ya fara aiki a ranar 27 ga Janairu, 2020. Amma bayanan bayanan da aka fitar don amsa buƙatun FOIA (kuma an haɗa su a cikin abin da ake kira "takardun Pfizer") sun nuna cewa wannan ba gaskiya ba ne kuma kamfanin ya riga ya fara gwaji, watau dabba, gwaji kusan makonni biyu da suka gabata, a ranar 14 ga Janairu.
Rahoton NAZARI na BioNTech R&D No. R-20-0072 yana nan nan. An kuma yi la'akari da rahoton kuma an tattauna shi a cikin ƙaddamar da FDA akan shirin binciken da ya dace nan. Hoton da ke ƙasa yana nuna kwanakin binciken daga p. 8 na rahoton.
A cikin littafin, Sahin ya yi ikirarin cewa har ma ya fara sha'awar barkewar cutar a Wuhan a ranar 24 ga Janairu, bayan karanta wata kasida a cikin mako-mako na Jamus. Der Spiegel (shafi na 4) da/ko biyayya ga The Lancet (shafi na 6). Amma sake duba kwanakin binciken da ke sama. BioNTech ta riga ta kammala binciken farko na farko na rigakafin Covid-19 a ranar da ta gabata!
Janairu 24, 2020 ta kasance Juma'a. A kan asusun Sahin, ya ɗauki matakin ƙaddamar da aikin rigakafinsa na Covid-19 a ƙarshen mako kuma ya bayyana shirinsa ga abokan aikinsa a hedkwatar BioNTech da ke Mainz, Jamus a ranar Litinin mai zuwa: 27 ga Janairu (ch. 2). wucewa kuma p. 42; duba hoton allo a kasa).
Sahin ya yi iƙirarin (shafi na 33) cewa a wannan taron na 27 ga Janairu ne ya nemi ƙungiyar gwajin dabbobi ta BioNTech da ta shirya shirye-shiryen da aka riga aka fara!
Ya kamata a sani cewa 14 ga Janairu, 2020, ranar da aka fara binciken farko na farko, makonni biyu ne kawai bayan rahoton farko na shari'ar Covid-19 a Wuhan kuma kwana guda bayan fitowar cutar. cikakken SARS-CoV-2 genome (an riga an fitar da daftarin aiki).
Binciken farko na BioNTech tabbas an shirya shi kafin buga kwayoyin halitta da kuma jiransa. Kamar yadda aka bayyana a cikin taƙaitaccen binciken (shafi na 6), manufarsa ita ce gwada BioNTech mRNA wanda aka tsara a cikin nau'in nanoparticles na lipid da kamfanin Kanada Acuitas ya samar. Amma mRNA yana nan yana ɓoye wani antigen (luciferase), ba furotin mai karu na SARS-CoV-2 wanda daga baya zai zama antigen da aka yi niyya.
Binciken ya kalli duka rarrabawar halittu da kunna tsarin rigakafi. Kamar yadda gabatar da FDA a kan shirin da ya dace ya sanya shi, "Kayan kayan aikin da ke tallafawa BNT162b2 an fara nuna su tare da antigens marasa SARS-CoV-2" (2.4 BAYANIN NONCLINICAL, shafi na 7).
In Alurar rigakafin, wanda aka rubuta tare da dan jarida Joe Miller, Sahin da Türeci sunyi magana game da buƙatar samun Acuitas lipids, wanda, sun ce, sun fi dacewa da allurar intramuscular fiye da na BioNTech na cikin gida. Amma, kuma, sun saka ranar al'amarin. Don haka, a p. 52, mun karanta: "Batun da ya ɓace har yanzu Acuitas ne, wanda bai riga ya yarda da yin amfani da lipids ɗinsu ba. Sa'an nan, a safiyar ranar Litinin 3 ga Fabrairu, [Acuitas CEO] Tom Madden ya ba da taimakonsa." Amma BioNTech ya riga ya gudanar da gwaje-gwaje ta amfani da Acuitas lipids makonni uku da suka gabata!
Bugu da ƙari, BioNTech bai iya tsara mRNA ɗin sa a cikin lipids ɗin kansa ba, amma ya dogara ga kamfanin Austriya Polymun don yin hakan. Kamar yadda aka ambata a cikin Alurar rigakafin (p.51), Wuraren Polymun tuƙi ne na awa 8 daga hedkwatar BioNTech a Mainz. A cikin littafin, Sahin da Türeci sun bayyana rukunin farko na mRNA don gwaje-gwajen rigakafin da suka dace an tattara su kuma a tuƙa su da mota zuwa Polymun a wajen Vienna: "Bayan kwanaki kaɗan, ƙaramin akwatin Styrofoam mai daskararre mai cike da alurar riga kafi za a mayar da shi kan iyaka zuwa BioNTech" (shafi na 116-117).
Amma mai yiwuwa wannan gaba-da-gaba dole ne ya faru tare da mRNA da ke ɓoye luciferase. Wannan yana nufin cewa a matsayin al'amari mai amfani "Project Lightspeed" dole ne ya fara farawa tun da farko: aƙalla kwanaki da yawa kafin ranar farawa na Janairu 14.
Me yasa Sahin da Türeci suka sanya ranar ƙaddamar da aikin rigakafin su na Covid-19 a cikin littafinsu? To, babu shakka saboda ainihin ranar farawa - kuma ba mu san lokacin da ainihin ranar farawa ta kasance ba - da alama ta yi nisa da wuri. Dangane da abubuwan da ke sama, dole ne ya kasance a ƙarshe kwanaki kaɗan bayan rahoton farko na 31 ga Disamba, 2019 na Covid-19 a Wuhan.
-
Robert Kogon shi ne sunan alkalami na wani ɗan jarida da ake bugawa da yawa wanda ke yin rubuce-rubuce kan al'amuran Turai.
Duba dukkan posts
